TP53 and breast carcinoma: Our data indicate that disruption of the TP53 pathway by high levels of MDM2 and MDMx are common events in the breast tumorigenesis and Mdmx amplifies quite frequently with low-level increase of gene copy number while few tumors with Mdm2 amplification are seen in primary breast cancers.